FDAnews Drug Daily Bulletin

Authorized Generic Deals May Be a Thing of the Past, Lawyer Says

Aug. 2, 2012
A A
Drug companies’ patent settlements may no longer need clauses preventing authorized generic (AG) launches after last month’s landmark court decision on pay-for-delay deals, a pharma lawyer says. Reverse settlements with side deals and other payments now will be presumed to be anticompetitive, Steve Maddox, partner with Knobbe Martens, said July 18.
Generic Line